APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pulmonary Function Testing Systems

Pulmonary Function Testing (PFT) is a complete evaluation of the respiratory system including patient history, physical examinations, chest x-ray examinations, arterial blood gas analysis, and tests of pulmonary function.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Pulmonary Function Testing (PFT) is a complete evaluation of the respiratory system including patient history, physical examinations, chest x-ray examinations, arterial blood gas analysis, and tests of pulmonary function.

The primary purpose of pulmonary function testing is to identify the severity of pulmonary impairment. Pulmonary function testing has diagnostic and therapeutic roles and helps clinicians answer some general questions about patients with lung disease.

Selected research

Industry Research

Pulmonary Function Testing Systems Industry Research Report 2026

21 December 2025129 pages

Choose your research edition.

Industry ResearchPulmonary Function Testing Systems Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Pulmonary Function Testing Systems Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Pulmonary Function Testing Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pulmonary Function Testing Systems Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pulmonary Function Testing Systems Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Pulmonary Function Testing (PFT) is a complete evaluation of the respiratory system including patient history, physical examinations, chest x-ray examinations, arterial blood gas analysis, and tests of pulmonary function.

The primary purpose of pulmonary function testing is to identify the severity of pulmonary impairment. Pulmonary function testing has diagnostic and therapeutic roles and helps clinicians answer some general questions about patients with lung disease.

Global Pulmonary Function Testing Systems main players are CareFusion(BD), Schiller, MGC Diagnostics, M&B, etc. Global top five manufacturers hold a share about 50%. Europe is the largest market, with a share about 30.

Read the full market overview

Report Scope

This report quantifies the global Pulmonary Function Testing Systems market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Pulmonary Function Testing Systems Market by Company

CareFusion(BD)

Schiller

CHEST

COSMED

nSpire Health

NDD

MGC Diagnostics

Minato

Ganshorn

AESRI

Morgan Scientific

M&B

Sikeda

RSDQ

Pulmonary Function Testing Systems Segment by Type

Portable PFT Systems

Complete PFT Systems

Pulmonary Function Testing Systems Segment by Application

Hospitals

Physical Examination Center

Physician Groups

Others

Pulmonary Function Testing Systems Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pulmonary Function Testing Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pulmonary Function Testing Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pulmonary Function Testing Systems.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Pulmonary Function Testing Systems manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Pulmonary Function Testing Systems by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Pulmonary Function Testing Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pulmonary Function Testing Systems Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Pulmonary Function Testing Systems Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Pulmonary Function Testing Systems Sales Market Share by Manufacturers (2021-2026) Table 8. Global Pulmonary Function Testing Systems Revenue of Manufacturers (2021-2026) Table 9. Global Pulmonary Function Testing Systems Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Pulmonary Function Testing Systems Average Price (USD/Unit) of Manufacturers (2021-2026) Table 11. Global Pulmonary Function Testing Systems Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Pulmonary Function Testing Systems, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Pulmonary Function Testing Systems, Product Type & Application Table 14. Global Pulmonary Function Testing Systems Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Pulmonary Function Testing Systems by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. CareFusion(BD) Company Information Table 19. CareFusion(BD) Business Overview Table 20. CareFusion(BD) Pulmonary Function Testing Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 21. CareFusion(BD) Pulmonary Function Testing Systems Product Portfolio Table 22. CareFusion(BD) Recent Developments Table 23. Schiller Company Information Table 24. Schiller Business Overview Table 25. Schiller Pulmonary Function Testing Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 26. Schiller Pulmonary Function Testing Systems Product Portfolio Table 27. Schiller Recent Developments Table 28. CHEST Company Information Table 29. CHEST Business Overview Table 30. CHEST Pulmonary Function Testing Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 31. CHEST Pulmonary Function Testing Systems Product Portfolio Table 32. CHEST Recent Developments Table 33. COSMED Company Information Table 34. COSMED Business Overview Table 35. COSMED Pulmonary Function Testing Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 36. COSMED Pulmonary Function Testing Systems Product Portfolio Table 37. COSMED Recent Developments Table 38. nSpire Health Company Information Table 39. nSpire Health Business Overview Table 40. nSpire Health Pulmonary Function Testing Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 41. nSpire Health Pulmonary Function Testing Systems Product Portfolio Table 42. nSpire Health Recent Developments Table 43. NDD Company Information Table 44. NDD Business Overview Table 45. NDD Pulmonary Function Testing Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 46. NDD Pulmonary Function Testing Systems Product Portfolio Table 47. NDD Recent Developments Table 48. MGC Diagnostics Company Information Table 49. MGC Diagnostics Business Overview Table 50. MGC Diagnostics Pulmonary Function Testing Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 51. MGC Diagnostics Pulmonary Function Testing Systems Product Portfolio Table 52. MGC Diagnostics Recent Developments Table 53. Minato Company Information Table 54. Minato Business Overview Table 55. Minato Pulmonary Function Testing Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 56. Minato Pulmonary Function Testing Systems Product Portfolio Table 57. Minato Recent Developments Table 58. Ganshorn Company Information Table 59. Ganshorn Business Overview Table 60. Ganshorn Pulmonary Function Testing Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 61. Ganshorn Pulmonary Function Testing Systems Product Portfolio Table 62. Ganshorn Recent Developments Table 63. AESRI Company Information Table 64. AESRI Business Overview Table 65. AESRI Pulmonary Function Testing Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 66. AESRI Pulmonary Function Testing Systems Product Portfolio Table 67. AESRI Recent Developments Table 68. Morgan Scientific Company Information Table 69. Morgan Scientific Business Overview Table 70. Morgan Scientific Pulmonary Function Testing Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 71. Morgan Scientific Pulmonary Function Testing Systems Product Portfolio Table 72. Morgan Scientific Recent Developments Table 73. M&B Company Information Table 74. M&B Business Overview Table 75. M&B Pulmonary Function Testing Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. M&B Pulmonary Function Testing Systems Product Portfolio Table 77. M&B Recent Developments Table 78. Sikeda Company Information Table 79. Sikeda Business Overview Table 80. Sikeda Pulmonary Function Testing Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Sikeda Pulmonary Function Testing Systems Product Portfolio Table 82. Sikeda Recent Developments Table 83. RSDQ Company Information Table 84. RSDQ Business Overview Table 85. RSDQ Pulmonary Function Testing Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. RSDQ Pulmonary Function Testing Systems Product Portfolio Table 87. RSDQ Recent Developments Table 88. Global Pulmonary Function Testing Systems Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 89. Global Pulmonary Function Testing Systems Sales by Region (2021-2026) & (K Units) Table 90. Global Pulmonary Function Testing Systems Sales Market Share by Region (2021-2026) Table 91. Global Pulmonary Function Testing Systems Sales by Region (2027-2032) & (K Units) Table 92. Global Pulmonary Function Testing Systems Sales Market Share by Region (2027-2032) Table 93. Global Pulmonary Function Testing Systems Revenue by Region (2021-2026) & (US$ Million) Table 94. Global Pulmonary Function Testing Systems Revenue Market Share by Region (2021-2026) Table 95. Global Pulmonary Function Testing Systems Revenue by Region (2027-2032) & (US$ Million) Table 96. Global Pulmonary Function Testing Systems Revenue Market Share by Region (2027-2032) Table 97. North America Pulmonary Function Testing Systems Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. North America Pulmonary Function Testing Systems Sales by Country (2021-2026) & (K Units) Table 99. North America Pulmonary Function Testing Systems Sales by Country (2027-2032) & (K Units) Table 100. North America Pulmonary Function Testing Systems Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Pulmonary Function Testing Systems Revenue by Country (2027-2032) & (US$ Million) Table 102. Europe Pulmonary Function Testing Systems Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Europe Pulmonary Function Testing Systems Sales by Country (2021-2026) & (K Units) Table 104. Europe Pulmonary Function Testing Systems Sales by Country (2027-2032) & (K Units) Table 105. Europe Pulmonary Function Testing Systems Revenue by Country (2021-2026) & (US$ Million) Table 106. Europe Pulmonary Function Testing Systems Revenue by Country (2027-2032) & (US$ Million) Table 107. Asia Pacific Pulmonary Function Testing Systems Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Asia Pacific Pulmonary Function Testing Systems Sales by Country (2021-2026) & (K Units) Table 109. Asia Pacific Pulmonary Function Testing Systems Sales by Country (2027-2032) & (K Units) Table 110. Asia Pacific Pulmonary Function Testing Systems Revenue by Country (2021-2026) & (US$ Million) Table 111. Asia Pacific Pulmonary Function Testing Systems Revenue by Country (2027-2032) & (US$ Million) Table 112. South America Pulmonary Function Testing Systems Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. South America Pulmonary Function Testing Systems Sales by Country (2021-2026) & (K Units) Table 114. South America Pulmonary Function Testing Systems Sales by Country (2027-2032) & (K Units) Table 115. South America Pulmonary Function Testing Systems Revenue by Country (2021-2026) & (US$ Million) Table 116. South America Pulmonary Function Testing Systems Revenue by Country (2027-2032) & (US$ Million) Table 117. Middle East and Africa Pulmonary Function Testing Systems Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Middle East and Africa Pulmonary Function Testing Systems Sales by Country (2021-2026) & (K Units) Table 119. Middle East and Africa Pulmonary Function Testing Systems Sales by Country (2027-2032) & (K Units) Table 120. Middle East and Africa Pulmonary Function Testing Systems Revenue by Country (2021-2026) & (US$ Million) Table 121. Middle East and Africa Pulmonary Function Testing Systems Revenue by Country (2027-2032) & (US$ Million) Table 122. Global Pulmonary Function Testing Systems Sales by Type (2021-2026) & (K Units) Table 123. Global Pulmonary Function Testing Systems Sales by Type (2027-2032) & (K Units) Table 124. Global Pulmonary Function Testing Systems Sales Market Share by Type (2021-2026) Table 125. Global Pulmonary Function Testing Systems Sales Market Share by Type (2027-2032) Table 126. Global Pulmonary Function Testing Systems Revenue by Type (2021-2026) & (US$ Million) Table 127. Global Pulmonary Function Testing Systems Revenue by Type (2027-2032) & (US$ Million) Table 128. Global Pulmonary Function Testing Systems Revenue Market Share by Type (2021-2026) Table 129. Global Pulmonary Function Testing Systems Revenue Market Share by Type (2027-2032) Table 130. Global Pulmonary Function Testing Systems Price by Type (2021-2026) & (USD/Unit) Table 131. Global Pulmonary Function Testing Systems Price by Type (2027-2032) & (USD/Unit) Table 132. Global Pulmonary Function Testing Systems Sales by Application (2021-2026) & (K Units) Table 133. Global Pulmonary Function Testing Systems Sales by Application (2027-2032) & (K Units) Table 134. Global Pulmonary Function Testing Systems Sales Market Share by Application (2021-2026) Table 135. Global Pulmonary Function Testing Systems Sales Market Share by Application (2027-2032) Table 136. Global Pulmonary Function Testing Systems Revenue by Application (2021-2026) & (US$ Million) Table 137. Global Pulmonary Function Testing Systems Revenue by Application (2027-2032) & (US$ Million) Table 138. Global Pulmonary Function Testing Systems Revenue Market Share by Application (2021-2026) Table 139. Global Pulmonary Function Testing Systems Revenue Market Share by Application (2027-2032) Table 140. Global Pulmonary Function Testing Systems Price by Application (2021-2026) & (USD/Unit) Table 141. Global Pulmonary Function Testing Systems Price by Application (2027-2032) & (USD/Unit) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Pulmonary Function Testing Systems Distributors List Table 145. Pulmonary Function Testing Systems Customers List Table 146. Pulmonary Function Testing Systems Industry Trends Table 147. Pulmonary Function Testing Systems Industry Drivers Table 148. Pulmonary Function Testing Systems Industry Restraints Table 149. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Pulmonary Function Testing Systems Product Image Figure 5. Global Pulmonary Function Testing Systems Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Pulmonary Function Testing Systems Market Size (2021-2032) & (US$ Million) Figure 7. Global Pulmonary Function Testing Systems Sales (2021-2032) & (K Units) Figure 8. Global Pulmonary Function Testing Systems Average Price (USD/Unit) & (2021-2032) Figure 9. Portable PFT Systems Product Image Figure 10. Complete PFT Systems Product Image Figure 11. Hospitals Product Image Figure 12. Physical Examination Center Product Image Figure 13. Physician Groups Product Image Figure 14. Others Product Image Figure 15. Global Pulmonary Function Testing Systems Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Pulmonary Function Testing Systems, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Pulmonary Function Testing Systems Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Pulmonary Function Testing Systems Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Pulmonary Function Testing Systems Sales by Region in 2025 Figure 21. Global Pulmonary Function Testing Systems Revenue by Region in 2025 Figure 22. North America Pulmonary Function Testing Systems Market Size by Country in 2025 Figure 23. North America Pulmonary Function Testing Systems Sales Market Share by Country (2021-2032) Figure 24. North America Pulmonary Function Testing Systems Revenue Market Share by Country (2021-2032) Figure 25. United States Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Pulmonary Function Testing Systems Market Size by Country in 2025 Figure 29. Europe Pulmonary Function Testing Systems Sales Market Share by Country (2021-2032) Figure 30. Europe Pulmonary Function Testing Systems Revenue Market Share by Country (2021-2032) Figure 31. Germany Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Pulmonary Function Testing Systems Market Size by Country in 2025 Figure 42. Asia Pacific Pulmonary Function Testing Systems Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Pulmonary Function Testing Systems Revenue Market Share by Country (2021-2032) Figure 44. China Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Pulmonary Function Testing Systems Market Size by Country in 2025 Figure 53. South America Pulmonary Function Testing Systems Sales Market Share by Country (2021-2032) Figure 54. South America Pulmonary Function Testing Systems Revenue Market Share by Country (2021-2032) Figure 55. Brazil Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Pulmonary Function Testing Systems Market Size by Country in 2025 Figure 59. Middle East and Africa Pulmonary Function Testing Systems Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Pulmonary Function Testing Systems Revenue Market Share by Country (2021-2032) Figure 61. Egypt Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Pulmonary Function Testing Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Pulmonary Function Testing Systems Sales Market Share by Type (2021-2032) Figure 67. Global Pulmonary Function Testing Systems Revenue Market Share by Type (2021-2032) Figure 68. Global Pulmonary Function Testing Systems Price (USD/Unit) by Type (2021-2032) Figure 69. Global Pulmonary Function Testing Systems Sales Market Share by Application (2021-2032) Figure 70. Global Pulmonary Function Testing Systems Revenue Market Share by Application (2021-2032) Figure 71. Global Pulmonary Function Testing Systems Price (USD/Unit) by Application (2021-2032) Figure 72. Pulmonary Function Testing Systems Value Chain Figure 73. Pulmonary Function Testing Systems Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Pulmonary Function Testing Systems Industry Opportunities and Challenges

Scope & coverage.

Types
  • Portable PFT Systems
  • Complete PFT Systems
Applications
  • Hospitals
  • Physical Examination Center
  • Physician Groups
  • Others
Companies covered
  • CareFusion(BD)
  • Schiller
  • CHEST
  • COSMED
  • nSpire Health
  • NDD
  • MGC Diagnostics
  • Minato
  • Ganshorn
  • AESRI
  • Morgan Scientific
  • M&B
  • Sikeda
  • RSDQ

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Pulmonary Function Testing Systems Market Size (2021-2032)
  4. 2.2.2 Global Pulmonary Function Testing Systems Sales (2021-2032)
  5. 2.2.3 Global Pulmonary Function Testing Systems Market Average Price (2021-2032)
  6. 2.3 Pulmonary Function Testing Systems by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Portable PFT Systems
  9. 2.3.3 Complete PFT Systems
  10. 2.4 Pulmonary Function Testing Systems by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospitals
  13. 2.4.3 Physical Examination Center
  14. 2.4.4 Physician Groups
  15. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Pulmonary Function Testing Systems Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Pulmonary Function Testing Systems Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Pulmonary Function Testing Systems Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Pulmonary Function Testing Systems Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Pulmonary Function Testing Systems Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Pulmonary Function Testing Systems, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Pulmonary Function Testing Systems, Product Type & Application
  8. 3.8 Global Manufacturers of Pulmonary Function Testing Systems, Established Date
  9. 3.9 Global Pulmonary Function Testing Systems Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 CareFusion(BD)
  2. 4.1.1 CareFusion(BD) Company Information
  3. 4.1.2 CareFusion(BD) Business Overview
  4. 4.1.3 CareFusion(BD) Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 CareFusion(BD) Pulmonary Function Testing Systems Product Portfolio
  6. 4.1.5 CareFusion(BD) Recent Developments
  7. 4.2 Schiller
  8. 4.2.1 Schiller Company Information
  9. 4.2.2 Schiller Business Overview
  10. 4.2.3 Schiller Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Schiller Pulmonary Function Testing Systems Product Portfolio
  12. 4.2.5 Schiller Recent Developments
  13. 4.3 CHEST
  14. 4.3.1 CHEST Company Information
  15. 4.3.2 CHEST Business Overview
  16. 4.3.3 CHEST Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 CHEST Pulmonary Function Testing Systems Product Portfolio
  18. 4.3.5 CHEST Recent Developments
  19. 4.4 COSMED
  20. 4.4.1 COSMED Company Information
  21. 4.4.2 COSMED Business Overview
  22. 4.4.3 COSMED Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 COSMED Pulmonary Function Testing Systems Product Portfolio
  24. 4.4.5 COSMED Recent Developments
  25. 4.5 nSpire Health
  26. 4.5.1 nSpire Health Company Information
  27. 4.5.2 nSpire Health Business Overview
  28. 4.5.3 nSpire Health Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 nSpire Health Pulmonary Function Testing Systems Product Portfolio
  30. 4.5.5 nSpire Health Recent Developments
  31. 4.6 NDD
  32. 4.6.1 NDD Company Information
  33. 4.6.2 NDD Business Overview
  34. 4.6.3 NDD Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 NDD Pulmonary Function Testing Systems Product Portfolio
  36. 4.6.5 NDD Recent Developments
  37. 4.7 MGC Diagnostics
  38. 4.7.1 MGC Diagnostics Company Information
  39. 4.7.2 MGC Diagnostics Business Overview
  40. 4.7.3 MGC Diagnostics Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 MGC Diagnostics Pulmonary Function Testing Systems Product Portfolio
  42. 4.7.5 MGC Diagnostics Recent Developments
  43. 4.8 Minato
  44. 4.8.1 Minato Company Information
  45. 4.8.2 Minato Business Overview
  46. 4.8.3 Minato Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Minato Pulmonary Function Testing Systems Product Portfolio
  48. 4.8.5 Minato Recent Developments
  49. 4.9 Ganshorn
  50. 4.9.1 Ganshorn Company Information
  51. 4.9.2 Ganshorn Business Overview
  52. 4.9.3 Ganshorn Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Ganshorn Pulmonary Function Testing Systems Product Portfolio
  54. 4.9.5 Ganshorn Recent Developments
  55. 4.10 AESRI
  56. 4.10.1 AESRI Company Information
  57. 4.10.2 AESRI Business Overview
  58. 4.10.3 AESRI Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 AESRI Pulmonary Function Testing Systems Product Portfolio
  60. 4.10.5 AESRI Recent Developments
  61. 4.11 Morgan Scientific
  62. 4.11.1 Morgan Scientific Company Information
  63. 4.11.2 Morgan Scientific Business Overview
  64. 4.11.3 Morgan Scientific Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Morgan Scientific Pulmonary Function Testing Systems Product Portfolio
  66. 4.11.5 Morgan Scientific Recent Developments
  67. 4.12 M&B
  68. 4.12.1 M&B Company Information
  69. 4.12.2 M&B Business Overview
  70. 4.12.3 M&B Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 M&B Pulmonary Function Testing Systems Product Portfolio
  72. 4.12.5 M&B Recent Developments
  73. 4.13 Sikeda
  74. 4.13.1 Sikeda Company Information
  75. 4.13.2 Sikeda Business Overview
  76. 4.13.3 Sikeda Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Sikeda Pulmonary Function Testing Systems Product Portfolio
  78. 4.13.5 Sikeda Recent Developments
  79. 4.14 RSDQ
  80. 4.14.1 RSDQ Company Information
  81. 4.14.2 RSDQ Business Overview
  82. 4.14.3 RSDQ Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 RSDQ Pulmonary Function Testing Systems Product Portfolio
  84. 4.14.5 RSDQ Recent Developments
5 Global Pulmonary Function Testing Systems Market Scenario by Region
  1. 5.1 Global Pulmonary Function Testing Systems Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Pulmonary Function Testing Systems Sales by Region: 2021-2032
  3. 5.2.1 Global Pulmonary Function Testing Systems Sales by Region: 2021-2026
  4. 5.2.2 Global Pulmonary Function Testing Systems Sales by Region: 2027-2032
  5. 5.3 Global Pulmonary Function Testing Systems Revenue by Region: 2021-2032
  6. 5.3.1 Global Pulmonary Function Testing Systems Revenue by Region: 2021-2026
  7. 5.3.2 Global Pulmonary Function Testing Systems Revenue by Region: 2027-2032
  8. 5.4 North America Pulmonary Function Testing Systems Market Facts & Figures by Country
  9. 5.4.1 North America Pulmonary Function Testing Systems Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Pulmonary Function Testing Systems Sales by Country (2021-2032)
  11. 5.4.3 North America Pulmonary Function Testing Systems Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Pulmonary Function Testing Systems Market Facts & Figures by Country
  16. 5.5.1 Europe Pulmonary Function Testing Systems Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Pulmonary Function Testing Systems Sales by Country (2021-2032)
  18. 5.5.3 Europe Pulmonary Function Testing Systems Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Pulmonary Function Testing Systems Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Pulmonary Function Testing Systems Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Pulmonary Function Testing Systems Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Pulmonary Function Testing Systems Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Pulmonary Function Testing Systems Market Facts & Figures by Country
  41. 5.7.1 South America Pulmonary Function Testing Systems Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Pulmonary Function Testing Systems Sales by Country (2021-2032)
  43. 5.7.3 South America Pulmonary Function Testing Systems Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Pulmonary Function Testing Systems Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Pulmonary Function Testing Systems Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Pulmonary Function Testing Systems Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Pulmonary Function Testing Systems Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Pulmonary Function Testing Systems Sales by Type (2021-2032)
  2. 6.1.1 Global Pulmonary Function Testing Systems Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Pulmonary Function Testing Systems Sales Market Share by Type (2021-2032)
  4. 6.2 Global Pulmonary Function Testing Systems Revenue by Type (2021-2032)
  5. 6.2.1 Global Pulmonary Function Testing Systems Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Pulmonary Function Testing Systems Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Pulmonary Function Testing Systems Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Pulmonary Function Testing Systems Sales by Application (2021-2032)
  2. 7.1.1 Global Pulmonary Function Testing Systems Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Pulmonary Function Testing Systems Sales Market Share by Application (2021-2032)
  4. 7.2 Global Pulmonary Function Testing Systems Revenue by Application (2021-2032)
  5. 7.2.1 Global Pulmonary Function Testing Systems Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Pulmonary Function Testing Systems Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Pulmonary Function Testing Systems Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Pulmonary Function Testing Systems Value Chain Analysis
  2. 8.1.1 Pulmonary Function Testing Systems Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Pulmonary Function Testing Systems Production Mode & Process
  5. 8.2 Pulmonary Function Testing Systems Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Pulmonary Function Testing Systems Distributors
  8. 8.2.3 Pulmonary Function Testing Systems Customers
9 Global Pulmonary Function Testing Systems Analyzing Market Dynamics
  1. 9.1 Pulmonary Function Testing Systems Industry Trends
  2. 9.2 Pulmonary Function Testing Systems Industry Drivers
  3. 9.3 Pulmonary Function Testing Systems Industry Opportunities and Challenges
  4. 9.4 Pulmonary Function Testing Systems Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst